Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39.1M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
3.96M
-
Shares change
-
-574K
-
Total reported value, excl. options
-
$4.77M
-
Value change
-
-$1.81M
-
Put/Call ratio
-
0.47
-
Number of buys
-
15
-
Number of sells
-
-28
-
Price
-
$1.22
Significant Holders of Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) as of Q2 2024
52 filings reported holding OCEA - Ocean Biomedical, Inc. - Common Stock, $0.0001 par value as of Q2 2024.
Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.96M shares
of 39.1M outstanding shares and own 10.11% of the company stock.
Largest 10 shareholders include Polar Asset Management Partners Inc. (2.69M shares), VANGUARD GROUP INC (407K shares), MILLENNIUM MANAGEMENT LLC (168K shares), GEODE CAPITAL MANAGEMENT, LLC (143K shares), BlackRock Inc. (99.9K shares), NORTHERN TRUST CORP (78.2K shares), GOLDMAN SACHS GROUP INC (65K shares), Verition Fund Management LLC (58.2K shares), JANE STREET GROUP, LLC (34.6K shares), and STATE STREET CORP (32.8K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.